News related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine) and/or conditions it is approved for
Doctors Stress Pressing Need For Research Into The Best Treatment For Medication Overuse Headaches
Source: Headache / Migraine News From Medical News Today [2008.11.03]
There is a critical need to review current treatment strategies for the increasingly common problem of medication overuse headaches (MOH), according to a series of international papers in the November issue of Cephalalgia. "MOH is associated with severe disability, unmet treatment need and little clinical data to support current management strategies" says neurology expert Professor David W Dodick from the Mayo Clinic College of Medicine, Arizona, USA.
Brain Cancer Symptoms: Headaches and Seizures
Source: MedicineNet Brain Tumor Specialty [2008.10.23]
Title: Brain Cancer Symptoms: Headaches and Seizures
Category: Doctor's Views
Created: 10/23/2008
Last Editorial Review: 10/23/2008
Pain In Chronic Headache Alleviated By Nerve Stimulation Therapy
Source: Headache / Migraine News From Medical News Today [2008.10.12]
A novel therapy using a miniature nerve stimulator instead of medication for the treatment of profoundly disabling headache disorders improved the experience of pain by 80-95 percent, according to a new study from the University of California, San Francisco and the National Hospital for Neurology and Neurosurgery in London.
Headache
Source: MedicineNet Brain Aneurysm Specialty [2008.09.30]
Title: Headache
Category: Diseases and Conditions
Created: 5/31/2002
Last Editorial Review: 9/30/2008
Children With Hay Fever More Likely To Experience Headaches, Facial Pain
Source: Headache / Migraine News From Medical News Today [2008.09.23]
Children who suffer from bouts of allergic rhinitis (hay fever) are also more likely to suffer from headaches, facial pain, and ear aches than children without these allergies, says new research presented at the 2008 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in Chicago, IL. Allergic rhinitis is a collection of symptoms predominantly in the nose and eyes, caused by airborne particles of dust, dander, or plant pollens.
Phase II Results Of COL-144 Presented At European Headache And Migraine Trust International Congress 2008
Source: Headache / Migraine News From Medical News Today [2008.09.08]
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches. COL-144 is a first-in-class Neurally Acting Anti- Migraine Agent (NAAMA), which unlike triptans, exhibits anti-migraine activity without causing vasoconstriction.
New Scientific Review Shows That Zolmitriptan ('Zomig(TM)') Nasal Spray Provided Efficacious Relief From Cluster Headache
Source: Headache / Migraine News From Medical News Today [2008.09.08]
Results from a new pooled data analysis presented at the European Headache and Migraine Trust International Congress (EHMTIC) 2008 today show that zolmitriptan ('Zomig') nasal spray provided fast and efficacious relief in the treatment of episodic and chronic cluster headache.
FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
Source: Headache / Migraine News From Medical News Today [2008.08.01]
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.
Cluster Headaches
Source: MedicineNet zolmitriptan Specialty [2005.02.04]
Title: Cluster Headaches
Category: Diseases and Conditions
Created: 2/4/2005 4:36:00 PM
Last Editorial Review: 2/4/2005 4:36:23 PM
500-Patient Study Measuring Cognitive Processing Efficiency During Migraine Attacks
Source: Headache / Migraine News From Medical News Today [2008.11.17]
PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials worldwide, is providing its innovative LogPad(R) System to help headache experts at Clinvest Clinical Research measure cognitive deficits during migraine attacks in a sponsored clinical trial. This is the first time cognitive processing time has been tested in a major migraine research study.
People in chronic pain show higher suicide risk (Reuters)
Source: Y! Health Depression News [2008.11.12]
Reuters - People with severe headaches or other forms of chronic pain may have an increased risk of suicide, a study published Tuesday suggests.
Pycnogenol Cut Jetlag Symptoms In Half For Passengers Taking 7- To 9-hour Flights
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2008.11.06]
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent. The two-part study, consisting of a brain CT scan and a scoring system, showed Pycnogenol lowered symptoms of jetlag such as fatigue, headaches, insomnia and brain edema (swelling) in both healthy individuals and hypertensive patients.
Women Who Have Migraines Have Lower Breast Cancer Risk
Source: Headache / Migraine News From Medical News Today [2008.11.06]
Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.
NovaDel Announces Data From Pilot Efficacy Study Comparing Sumatriptan Oral Spray To Imitrex(R) Tablets
Source: Headache / Migraine News From Medical News Today [2008.09.06]
NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan (Sumatriptan OS) compared to sumatriptan tablets, marketed as Imitrex®/Imigran®, the leading triptan indicated for the treatment of migraine headaches.
Army Personnel Show Increased Risk For Migraine - Condition Underdiagnosed, Mistreated
Source: Headache / Migraine News From Medical News Today [2008.08.29]
Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees. The U.S.
|
